Persistence can pay off. After years of struggle, Epitope, Inc. of Beaverton, Oregon received a big “shot inthe arm” when the Journal of the American Medical Association (JAMA) reported this month on a clinical study involving Epitope’s OraSure HIV test. The study involved 3,570 patients. It matched results of an HIV blood test against the
Subscriber-Only Content. Please Log In.
You are trying to access subscribers-only content. If you are a subscriber, please log in.
If you are not a subscriber, click here to see subscription offers.
Subscribers will have instant access to the Dark Report library, 1997 - the present, giving you the most convenient, accessible archive available in laboratory business intelligence today!
To read our FREE article previews, go to The Dark Report Insider.